Zacks Research upgraded shares of Itron (NASDAQ:ITRI – Free Report) from a hold rating to a strong-buy rating in a report released on Thursday morning,Zacks.com reports.
A number of other equities analysts also recently weighed in on ITRI. Robert W. Baird set a $125.00 target price on Itron in a report on Wednesday, July 29th. Roth Capital restated a “buy” rating and set a $136.00 price target on shares of Itron in a report on Wednesday, April 29th. Seaport Research Partners reiterated a “buy” rating and issued a $150.00 price objective on shares of Itron in a research note on Wednesday, July 29th. Weiss Ratings reissued a “hold (c)” rating on shares of Itron in a research note on Wednesday, August 5th. Finally, TD Cowen cut their price objective on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $131.33.
View Our Latest Stock Analysis on Itron
Itron Price Performance
Itron (NASDAQ:ITRI – Get Free Report) last issued its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%.The business had revenue of $562.90 million during the quarter, compared to analysts’ expectations of $566.34 million. During the same quarter last year, the firm posted $1.62 earnings per share. Itron’s revenue was down 7.2% compared to the same quarter last year. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities analysts expect that Itron will post 6.41 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CFO Joan S. Hooper sold 4,406 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $98.86, for a total transaction of $435,577.16. Following the completion of the sale, the chief financial officer owned 117,113 shares in the company, valued at $11,577,791.18. This represents a 3.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 331 shares of Itron stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $98.79, for a total value of $32,699.49. Following the completion of the transaction, the senior vice president directly owned 12,683 shares in the company, valued at approximately $1,252,953.57. This represents a 2.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 7,693 shares of company stock valued at $759,475. Insiders own 1.77% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in ITRI. Capital World Investors bought a new position in Itron during the fourth quarter valued at about $10,460,000. Assenagon Asset Management S.A. grew its holdings in shares of Itron by 160.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company’s stock worth $29,136,000 after purchasing an additional 207,416 shares in the last quarter. DNB Asset Management AS acquired a new stake in shares of Itron during the 4th quarter worth approximately $12,191,000. WINTON GROUP Ltd bought a new stake in shares of Itron during the fourth quarter valued at approximately $5,795,000. Finally, Fieldview Capital Management LLC raised its stake in shares of Itron by 54.1% in the fourth quarter. Fieldview Capital Management LLC now owns 40,095 shares of the scientific and technical instruments company’s stock valued at $3,723,000 after purchasing an additional 14,079 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.
Itron Company Profile
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Read More
- Five stocks we like better than Itron
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
